To meet your need to know who's new in the orthopaedic market, I sorted through 21 companies receiving their first orthopaedic-related FDA 510(k) clearance, then chose one company from each implantable market segment for a closer look. Here's what I found.
The study tracked 50 degenerative disease patients with an average age of 60 who underwent anterior cervical discectomy and fusion with a Cohere device, with 100% of participants experiencing positive results.
The inlay design of the implant presents an anatomic approach to treating a loss of cartilage that is limited to the central knee joint, and is an alternative to onlay implants.
Supplier M&A activity is a significant story in orthopaedics this year. We provide tips and actionable advice in the event that one of your important suppliers is merged with or acquired by another.
A strategic planning process (SPP) provides a systematic way of mapping the handful of key decisions that an organization must get right in order to survive--and thrive--during the next several years. We provide six steps to implement an effective SPP at your company.
